Children's Tumor Foundation
Standards For Charity Accountability
Governance
-
Board Oversight
-
Board Size
-
Board Meetings
-
Board Compensation
-
Conflict of Interest
Measuring Effectiveness
-
Effectiveness Policy
-
Effectiveness Report
Finances
-
Program Expenses
-
Fundraising Expenses
-
Accumulating Funds
-
Audit Report
-
Detailed Expense Breakdown
-
Accurate Expense Reporting
-
Budget Plan
Fundraising & Info
-
Truthful Materials
-
Annual Report
-
Website Disclosures
-
Donor Privacy
-
Cause Marketing Disclosures
-
Complaints
Children's Tumor Foundation does not meet the following 2 Standards for Charity Accountability:
Standard 6 (Board Policy on Effectiveness)
Have a board policy of assessing, no less than every two years, the organization's performance and effectiveness and of determining future actions required to achieve its mission.
CTF does not meet this Standard because:
- The board of directors does not have a written policy stating that, at least every two years, an appraisal be done assessing the organization’s performance and effectiveness and determining future actions required to achieve its mission.
Standard 7 (Board Approval of Written Report on Effectiveness)
Submit to the organization's governing body, for its approval, a written report that outlines the results of the aforementioned performance and effectiveness assessment and recommendations for future actions.
CTF does not meet this Standard because:
- The organizaiton has not completed an effectiveness assessment in the last two years.
Children's Tumor Foundation meets the remaining 18 Standards for Charity Accountability.
Stated Purpose:
"to drive research, expand knowledge, and advance care for the neurofibromatosis community."
Year, State Incorporated:
1978, NY
By connecting patients, doctors, scientists, and pharma, Children's Tumor Foundation (CTF) reports that it drives treatments, advances care, and delivers results for millions affected by neurofibromatosis or schwannomatosis, collectively referred to as NF. The organization reports that its patient-first, collaborative approach accelerates drug development and brings life-changing therapies to patients faster.
For the year ended December 31, 2023, Children's Tumor Foundation's program expenses were:
Research and medical: $10,429,683
Public education and patient support: $5,650,326
Total Program Expenses: $16,080,009
Chief Executive
Annette Bakker, Chief Executive Officer
Compensation*
$472,045
Chair of the Board
Gabriel Groisman
Chair's Profession / Business Affiliation
Attorney, LSN Partners, LLC
Board Size
18
Paid Staff Size
47
*2023 compensation includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.
Method(s) Used:
Direct mail appeals, Grant proposals, Internet, Direct mail appeals, Radio
Fundraising costs were 8% of related contributions. (Related contributions, which totaled $15,955,747, are donations received as a result of fundraising activities.)
This organization is tax-exempt under section 501(c)(3) of the Internal Revenue Code. It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.
The following information is based on Children's Tumor Foundation's audited financial statements for the year ended December 31, 2023.
Source of Funds
Investment activity | $1,438,619 |
Individual contributions | $7,375,454 |
Corporations and foundations | $4,161,398 |
Bequests | $544,494 |
In-kind contributions | $488,964 |
Other | $158,890 |
Government grants | $178,253 |
Special events, net | $3,048,294 |
Total Income | $17,394,366 |
Programs: 84% Fundraising: 7% Administrative: 10%
Total Income | $17,394,366 |
Total expenses: | $19,226,531 |
Program expenses | $16,080,009 |
Fundraising expenses | $1,261,974 |
Administrative expenses | $1,884,548 |
Other expenses | $0 |
Income in Excess of Expenses | $-1,832,165 |
Beginning Net Assets | $27,681,382 |
Other Changes In Net Assets | $1,161 |
Ending Net Assets | $25,850,378 |
Total Liabilities | $4,344,341 |
Total Assets | $30,194,719 |
Note 1: For the year ended December 31, 2023, Children's Tumor Foundation reported in-kind donations totaling $488,964 including advertising ($255,503), legal and professional fees ($122,351), raffle and auction items ($74,134), other ($35,796), and event food ($1,180).
Note 2: In the financial summary above, "other changes in net assets" refers to gain on foreign currency translation.
An organization may change its practices at any time without notice. A copy of this report has been shared with the organization prior to publication. It is not intended to recommend or deprecate, and is furnished solely to assist you in exercising your own judgment. If the report is about a charity and states the charity meets or does not meet the Standards for Charity Accountability, it reflects the results of an evaluation of information and materials provided voluntarily by the charity. The name Better Business Bureau is a registered service mark of the International Association of Better Business Bureaus.
This report is not to be used for fundraising or promotional purposes.